BeStock  
Stocks › Biotechnology › ADMA

ADMA Biologics ADMA

US equityMarket cap rank #2693Biotechnology
$10.11 +$0.39 (+4.01%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $10.20 +0.89%
Open$9.63
Prev close$9.72
Day range$9.62 – $10.19
Volume3.51M
Market cap$2.26B
P/E (TTM)14.4
Dividend yield–

Where the revenue comes from

Quarter 2026/Q2

By business line

  • ADMA BioManufacturing$123.64M 99.4%
  • Plasma Collection Centers$723,000.00 0.6%
  • License revenue$35,000.00 0.0%

Cash flow

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Operating Cash Flow $50.40M $118.67M $8.80M -$59.51M -$112.37M
-Change in Other Current Liabilities -$1.23M -$1.14M -$791,000.00 -$502,000.00 $219,000.00
Free Cash Flow $27.51M $110.10M $3.82M -$73.42M -$125.88M
-Change in Prepaid Assets -$1.25M -$2.68M $841,000.00 -$634,000.00 -$3.07M
-Change in Inventory -$36.23M $2.67M -$9.63M -$38.56M -$43.19M
-Change in Receivables -$108.43M -$22.58M -$11.92M $13.07M -$15.34M
Change in Working Capital -$139.60M -$18.54M -$10.12M -$18.29M -$51.68M
Other Non-Cash Items $574,000.00 $808,000.00 $6.29M $5.26M $1.75M
Deferred Tax $11.02M -$84.28M $0.00 $0.00 –
Depreciation & Depletion & Amortization $8.10M $8.05M $8.33M $7.11M $5.50M
Gain/Loss from Continuing Operations $3.35M $1.35M $26.36M $7.10M $221,000.00
Net Income from Continuing Operations $146.93M $197.67M -$28.24M -$65.90M -$71.65M
Net cash flow from continuing operations $50.40M $118.67M $8.80M -$59.51M -$112.37M
Net cash flow from investing -$21.89M -$8.58M -$4.98M -$13.91M -$13.51M
Net Cash Flow from Continuing Investing Activities -$21.89M -$8.58M -$4.98M -$13.91M -$13.51M
-Change in Payables and Accrued Expense $7.54M $5.19M $11.37M $8.33M $9.70M
Beginning Cash Balance $103.15M $51.35M $86.52M $51.09M $55.92M
Net Change in Cash -$15.52M $51.80M -$35.17M $35.43M -$4.83M
Ending Cash Balance $87.63M $103.15M $51.35M $86.52M $51.09M
Net Other Financing Charges -$14.13M -$5.80M -$16.49M -$7.68M -$62,000.00
Proceeds from Stock Option Exercised $2.98M $7.49M $1.10M $175,000.00 $0.00
Net Common Stock Issuance -$31.94M $0.00 $0.00 $64.65M $121.14M
Net Issuance Payments Of Debt -$938,000.00 -$60.00M -$23.60M $51.71M -$34,000.00
Net Cash Flow from Continuing Financing Activities -$44.02M -$58.30M -$38.99M $108.85M $121.05M
Financing Cash Flow -$44.02M -$58.30M -$38.99M $108.85M $121.05M
Net Other Investing Changes $1.00M – – – –
Net Intangibles Purchase and Sale -$316,000.00 -$349,000.00 -$210,000.00 $0.00 $0.00
Net PPE Purchase and Sale -$22.58M -$8.23M -$4.77M -$13.91M -$13.51M

Discussion

No comments yet — be the first to weigh in on ADMA.

Leave a comment

Scroll to Top